Definition of Reopro. Meaning of Reopro. Synonyms of Reopro

Here you will find one or more explanations in English for the word Reopro. Also in the bottom left of the page several parts of wikipedia pages related to the word Reopro and, of course, Reopro synonyms and on the right images related to the word Reopro.

Definition of Reopro

No result for Reopro. Showing similar results...

Meaning of Reopro from wikipedia

- Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitor mainly used during and after coronary...
- antiplatelet agents. Several GpIIb/IIIa inhibitors exist: abciximab (abcixifiban) (ReoPro) eptifibatide (Integrilin) tirofiban (Aggrastat) roxifiban orbofiban Glycoprotein...
- Tretinoin. Renovist Renovue rentiapril (INN) renytoline (INN) renzapride (INN) ReoPro (Eli Lilly). Redirects to abciximab. repagermanium (INN) repaglinide (INN)...
- (Persantine) Glycoprotein IIB/IIIA inhibitors (intravenous use only) Abciximab (ReoPro) Eptifibatide (Integrilin) Tirofiban (Aggrastat) Irreversible cyclooxygenase...
- Examples of chimeric antibodies approved for human therapy include abciximab (ReoPro), basiliximab (Simulect), cetuximab (Erbitux), infliximab (Remicade) and...
- at Columbia reached the market. These include Remicade (for arthritis), Reopro (for blood clot complications), Xalatan (for glaucoma), Benefix, Latanoprost...
- ever win approval as a drug, ReoPro marked a milestone for both Centocor and for monoclonal antibodies therapeutics. ReoPro was to be followed in August...
- approved for plaque psoriasis in September 2006. Centocor also markets ReoPro (abciximab), a biologic agent indicated as an adjunct to coronary angioplasty...
- Type Target Indication (Targeted disease) BLA STN Drug Label abciximab ReoPro Centocor 12/22/1994 intravenous chimeric Fab GPIIb/IIIa Percutaneous coronary...
- Archived (PDF) from the original on 15 July 2020. Retrieved 23 January 2020. "ReoPro Abciximab". DailyMed. 4 May 2020. Archived from the original on 6 September...